Diawara Idrissa, Barguigua Abouddihaj, Katfy Khalid, Nayme Kaotar, Belabbes Houria, Timinouni Mohammed, Zerouali Khalid, Elmdaghri Naima
Laboratoire de Microbiologie, Faculté de Médecine et de Pharmacie, Hassan II University of Casablanca, B.P 5696, Casablanca, Morocco.
Service de Microbiologie, CHU Ibn Rochd, B.P 2698, Casablanca, Morocco.
Ann Clin Microbiol Antimicrob. 2017 Apr 4;16(1):23. doi: 10.1186/s12941-017-0200-6.
Streptococcus pneumoniae is a major cause of morbidity and mortality worldwide, especially among children and the elderly. The ability to effectively treat pneumococcal infection has been compromised due to the acquisition of antibiotic resistance, particularly to β-lactam drugs. This study aimed to describe the prevalence and molecular evolution of penicillin non-susceptible S. pneumoniae (PNSP) isolated from invasive diseases before and after pneumococcal conjugate vaccine implementation in Casablanca, Morocco.
Isolates were obtained from the Microbiology Laboratory of Ibn Rochd University Hospital Centre of Casablanca. Serogrouping was done by Pneumotest Kit and serotyping by the Quellung capsular swelling. Antibiotic susceptibility pattern was determined by disk diffusion and E-test methods. The PNSP were analyzed by pulsed-field gel electrophoresis (PFGE) and by genotyping of pbp1a, pbp2b, and pbp2x genes.
A total of 361 S. pneumoniae isolates were collected from 2007 to 2014. Of these isolates, 58.7% were obtained before vaccination (2007-2010) and 41.3% after vaccination (2011-2014). Of the 361 isolates, 80 were PNSP (22.2%). Generally, the proportion of PNSP between pre- and post-vaccination periods were 31 and 13% (p = 0.009), respectively. The proportion of PNSP isolated from pediatric and adult (age > 14 years) patients decreased from 34.5 to 22.9% (p = 0.1) and from 17.7 to 10.2% (p = 0.1) before and after vaccine implementation, respectively. The leading serotypes of PNSP were 14 (33 vs. 57%) and 19A (18 vs. 14%) before and after vaccination among children. For adults, serotypes 19A (53%) and 23F (24%) were the dominant serotypes in the pre-vaccination period, while serotype 14 (22%) was the most prevalent after vaccination. There were 21 pbp genotypes in the pre-vaccination period vs. 12 for post-vaccination period. PFGE clustering showed six clusters of PNSP grouped into three clusters specific to pre-vaccination period (clusters I, II and III), two clusters specific to post-period (clusters V and VI) and a cluster (IV) that contained clones belonging to the two periods of vaccination.
Our observations demonstrate a high degree of genetic diversity among PNSP. Genetic clustering among PNSP strains showed that they spread mainly by a restricted number of PNSP clones with vaccine serotypes. PFGE clustering combined with pbp genotyping revealed that vaccination can change the population structure of PNSP.
肺炎链球菌是全球发病和死亡的主要原因,尤其是在儿童和老年人中。由于获得了抗生素耐药性,特别是对β-内酰胺类药物的耐药性,有效治疗肺炎球菌感染的能力受到了损害。本研究旨在描述在摩洛哥卡萨布兰卡实施肺炎球菌结合疫苗前后,从侵袭性疾病中分离出的青霉素不敏感肺炎链球菌(PNSP)的流行情况和分子进化。
分离株来自卡萨布兰卡伊本·罗奇德大学医院中心微生物实验室。使用肺炎球菌检测试剂盒进行血清群鉴定,采用荚膜肿胀反应进行血清型鉴定。通过纸片扩散法和E试验方法确定抗生素敏感性模式。采用脉冲场凝胶电泳(PFGE)以及pbp1a、pbp2b和pbp2x基因分型对PNSP进行分析。
2007年至2014年共收集到361株肺炎链球菌分离株。其中,58.7%的分离株在疫苗接种前(2007 - 2010年)获得,41.3%在疫苗接种后(2011 - 2014年)获得。在这361株分离株中,有80株为PNSP(22.2%)。总体而言,疫苗接种前和接种后PNSP的比例分别为31%和13%(p = 0.009)。从儿科和成人(年龄>14岁)患者中分离出的PNSP比例在疫苗接种实施前后分别从34.5%降至22.9%(p = 0.1)和从17.7%降至10.2%(p = 0.1)。儿童中PNSP的主要血清型在疫苗接种前和接种后分别为14型(33%对57%)和19A 型(18%对14%)。对于成人,疫苗接种前19A 型(53%)和23F 型(24%)是主要血清型,而疫苗接种后14型(22%)最为常见。疫苗接种前有21种pbp基因型,疫苗接种后有12种。PFGE聚类显示PNSP有六个簇,分为疫苗接种前特有的三个簇(簇I、II和III)、疫苗接种后特有的两个簇(簇V和VI)以及一个包含属于两个疫苗接种时期克隆的簇(簇IV)。
我们的观察结果表明PNSP之间存在高度的遗传多样性。PNSP菌株之间的遗传聚类表明它们主要通过数量有限的带有疫苗血清型的PNSP克隆传播。PFGE聚类与pbp基因分型相结合表明疫苗接种可改变PNSP的种群结构。